StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.35+0.10 (+1.21%)

Close on Nov 13, 2026Market cap $3.13BP/E –Yield –

Bausch Health Companies profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Bausch Health Companies's profit margin for the twelve months ending Sep 30, 2026 was -7.6%. For fiscal 2025 it was 1.5%, against -0.5% the year before. The highest annual figure on record is 1.5% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20251.5%+2.0
FY2024Dec 31, 2024-0.5%+6.3
FY2023Dec 31, 2023-6.8%−4.0
FY2022Dec 31, 2022-2.8%+8.5
FY2021Dec 31, 2021-11.2%−4.3
FY2020Dec 31, 2020-7.0%+13.8
FY2019Dec 31, 2019-20.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202614.8%+8.1
Q2 FY2026Jun 30, 20269.0%+3.2
Q1 FY2026Mar 31, 2026-56.4%−53.8
Q4 FY2025Dec 31, 2025-4.0%−7.6
Q3 FY2025Sep 30, 20256.7%+10.1
Q2 FY2025Jun 30, 20255.8%+5.4
Q1 FY2025Mar 31, 2025-2.6%+0.4
Q4 FY2024Dec 31, 20243.6%+5.3
Q3 FY2024Sep 30, 2024-3.4%+13.5
Q2 FY2024Jun 30, 20240.4%−0.8
Q1 FY2024Mar 31, 2024-3.0%+7.4
Q4 FY2023Dec 31, 2023-1.6%+17.1
Q3 FY2023Sep 30, 2023-16.9%−36.4
Q2 FY2023Jun 30, 20231.2%+8.6
Q1 FY2023Mar 31, 2023-10.3%−6.7
Q4 FY2022Dec 31, 2022-18.7%−21.8
Q3 FY2022Sep 30, 202219.5%+10.6
Q2 FY2022Jun 30, 2022-7.4%+21.0
Q1 FY2022Mar 31, 2022-3.6%+26.5
Q4 FY2021Dec 31, 20213.1%+10.1
Q3 FY2021Sep 30, 20218.9%+5.6
Q2 FY2021Jun 30, 2021-28.3%−8.7
Q1 FY2021Mar 31, 2021-30.1%−22.5
Q4 FY2020Dec 31, 2020-6.9%–
Q3 FY2020Sep 30, 20203.3%–
Q2 FY2020Jun 30, 2020-19.6%–
Q1 FY2020Mar 31, 2020-7.6%–

More Bausch Health Companies figures

See a number that looks wrong?